Dr. Idit Golani
Optimization of drug treatment for nervous system diseases
This research delves into central nervous system diseases and their treatments, emphasizing psychiatric disorders (anxiety, depression, schizophrenia) and neurodegenerative diseases (Alzheimer’s). The study explores novel pathways and compounds for treatment and technologies to deliver existing drugs efficiently to the brain, minimizing side effects and enhancing patient compliance.
